Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
致癌性TRK融合基因可通过抑制治疗血液系统恶性肿瘤。
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI120787
Taylor, Justin; Pavlick, Dean; Yoshimi, Akihide; Marcelus, Christina; Chung, Stephen S; Hechtman, Jaclyn F; Benayed, Ryma; Cocco, Emiliano; Durham, Benjamin H; Bitner, Lillian; Inoue, Daichi; Chung, Young Rock; Mullaney, Kerry; Watts, Justin M; Diamond, Eli L; Albacker, Lee A; Mughal, Tariq I; Ebata, Kevin; Tuch, Brian B; Ku, Nora; Scaltriti, Maurizio; Roshal, Mikhail; Arcila, Maria; Ali, Siraj; Hyman, David M; Park, Jae H; Abdel-Wahab, Omar